What are the side effects of Mounjaro, and how common are they?

What the SURMOUNT-1 trial data actually showed

A lot of people assume that a medicine producing average weight loss of around 20% over 72 weeks must come with a brutal list of side effects. The picture from the trial data is more nuanced than that. In SURMOUNT-1, published in the New England Journal of Medicine, gastrointestinal effects were the most common reason participants reported discomfort — but the large majority of those events were graded mild to moderate, and most occurred around the time of a dose increase rather than persisting throughout treatment.

Nausea was the most frequently reported, followed by diarrhoea, vomiting and constipation. Burping, reflux and a feeling of fullness after small meals were also noted. Injection-site reactions, headache, dizziness and fatigue appeared less often. These patterns are consistent with what the NHS medicines guidance for tirzepatide describes, the NHS tirzepatide page lists the common, uncommon and rare effects drawn from the licensed product information, and it is worth reading alongside this page.

One misconception worth setting aside gently: the idea that Mounjaro simply suppresses appetite by making you feel ill. If you are curious about what people actually experience when taking Mounjaro, it is worth knowing that the nausea, where it occurs, is largely a consequence of slowed gastric emptying during the adjustment phase, it is not the mechanism by which the medicine works. Most people who do experience it find it fades. A smaller number find it persistent enough to stay at a lower dose for longer, which is a legitimate clinical decision.

Serious side effects: what needs urgent medical attention

The serious side effects are infrequent but important to know before you start. Acute pancreatitis is the one the MHRA has highlighted most directly: in January 2026 the regulator published a Drug Safety Update specifically for GLP-1 medicines including tirzepatide, flagging pancreatitis as a known but uncommon risk that can be severe. The symptom to act on is intense, persistent stomach pain that spreads toward the back, which may or may not come with vomiting. This warrants same-day emergency assessment, not a wait-and-see approach.

Other situations that need prompt medical contact include: signs of a gallbladder problem (pain in the upper right abdomen, fever, yellowing of the skin), symptoms of dehydration following severe vomiting or diarrhoea, any allergic reaction (rash, swelling of the face or throat, difficulty breathing), and (for people being treated for diabetes alongside weight management) symptoms of low blood sugar if combined with other glucose-lowering medicines.

Sudden changes in vision should also be reported to a healthcare professional promptly. If you are ever uncertain whether a symptom is linked to treatment, contacting a pharmacist or GP is always reasonable. For those on tirzepatide through nume, priority aftercare is available seven days a week, not just during a Monday morning window. You can also report any suspected side effect directly to the MHRA at any time via the Yellow Card scheme.

Side effects specific to tirzepatide that are worth flagging before you start

Because tirzepatide activates two receptors (GIP and GLP-1) rather than one, its profile differs in a couple of practical ways from semaglutide-based treatments. The most relevant for many women is the contraceptive pill interaction. NHS guidance confirms that oral contraceptives may be absorbed less reliably during the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because the medicine slows how quickly the stomach empties. Adding a non-oral method of contraception during those windows is the recommended approach, something our prescribers discuss as part of the consultation rather than leaving to a leaflet.

There is also specific NHS England advice that women taking HRT may wish to consider transdermal forms (patches or gels) for the same absorption reason, and that anyone due surgery should tell their anaesthetist they are on this medicine. If you are on other medications, the prescriber's review covers potential interactions, this is part of why a full clinical assessment, not a quick online tick-box, is the appropriate route to treatment. Our page covering what the side effects of Mounjaro are goes into further detail on the full licensed profile, and more detail on how tirzepatide compares to other options is on our weight-loss treatments overview.

For a thorough look at longer-term considerations, our page on Mounjaro's long-term side effects covers what the extended trial data and post-marketing surveillance tell us so far. And if back pain is something you have noticed or are worried about, we address that specifically here.

How a prescriber-led service changes the experience of starting Mounjaro

Side effects are not just a list to read and accept. How the dose is introduced, how quickly it is increased, and whether a slower titration is warranted for you personally, these decisions genuinely affect how someone tolerates treatment. A clinical review that takes your full history into account can identify in advance whether you are at higher baseline risk for certain effects, or whether a particular combination of medicines needs closer attention.

At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber. A real clinician reads your answers, the same person who decides whether to issue the prescription. That review is included in the price, as is aftercare if questions arise once treatment starts. If you want to read a plain-English breakdown of what the side effects of Mounjaro are before committing, that page covers the full picture, and if you want to talk through your specific situation, starting a free consultation is the place to do that, our prescribers cover suitability and likely tolerance as standard. You can also read more about our clinical team on our prescribers page.